VENN STRATEGIES, LLC

Lobbying for BIOMARIN PHARMACEUTICAL, INC. · Develops & commercializes innovative biopharmaceuticals for serious diseases

Filing 2nd Quarter - Amendment

2nd Quarter (Apr 1 - June 30) 2017 · California · House · Senate · $30,000.00 income · posted Jul 6, 2026

Lobbying activity 2

Health Issues

Orphan drugs and rare diseases, matters related to drug reimbursement policy.

Taxation/Internal Revenue Code

Orphan drugs and rare disease matters

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.